Alzheimer’s Disease Related Content

It’s a fact of life that our brains change as we grow older, and as they do, we might notice some subtle differences in the way they work. Aging adults are often increasingly prone to misplacing items or struggling to recall something from the past, for example. These shifts are natural and pose no...

Dr. Brent Forester, chief of McLean’s Division of Geriatric Psychiatry, shares an update on the evaluation and management of Alzheimer’s Disease and related disorders and what’s new in 2020.

Keith Fargo, PhD, Alzheimer’s Association, presents View From the Alzheimer’s Association, as part of the panel Digital Mental Health and Aging: Emerging Perspectives. These remarks were part of the 2019 Technology in Psychiatry Summit, an event sponsored by the McLean Institute for Technology in...

Presented by Brent P. Forester, MD, MSc, McLean Hospital, and Liz McCarthy, Alzheimer’s Association, Massachusetts/New Hampshire Chapter – McLean Forum lecture Recent studies by the Alzheimer’s Association show that Alzheimer’s disease affects nearly six million people in the U.S. It is the sixth...

Bob’s complicated story includes multiple diagnoses, including Alzheimer’s disease. Watch Bob and his wife, Donna, navigate this journey with the help of McLean’s Dr. Brent Forester.

Presented by Nancy J. Donovan, MD, Brigham and Women’s Hospital – Visiting Scholar Series lecture Alzheimer’s disease (AD) begins with a long preclinical stage defined by the abnormal accumulation of amyloid-beta and tau proteins. Using neuroimaging, these pathological proteins, or “biomarkers,” can...

McLean Forum Brent P. Forester, MD, MSc, McLean Hospital